0001213900-23-019384.txt : 20230313
0001213900-23-019384.hdr.sgml : 20230313
20230313080020
ACCESSION NUMBER: 0001213900-23-019384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Harlan F
CENTRAL INDEX KEY: 0001555563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 23725755
MAIL ADDRESS:
STREET 1: C/O CORONADO BIOSCIENCES, INC.
STREET 2: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0306
4
2023-03-10
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001555563
Weisman Harlan F
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
1
1
0
0
President and CEO
Common Stock
2023-03-10
4
P
0
150000
0.8789
A
214615
D
The reported shares were purchased in the open market in one transaction at the price of $0.8789.
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
2023-03-13